Aclaris Therapeutics, Inc. (0H8T.L) LSE
4.62
+0.095(+2.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.62
+0.095(+2.10%)
Currency In USD
| Market Cap | 366.47M |
| Enterprise Value | 350.19M |
| P/E Ratio | -8.56 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 66.73 |
| Price/Book Ratio | 4.15 |
| Enterprise/Revenue | 63.54 |
| Enterprise/EBITDA | -7.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.33 |
| Operating Margin | -9.62 |
| Return On Assets | -0.35 |
| Return On Equity | -0.56 |
| Revenue | 7.83M |
| Revenue/Share | 0.06 |
| Gross Profit | 542,000 |
| EBITDA | -73.42M |
| Net Income | -64.92M |
| Diluted EPS | -0.53 |
| Total Cash | 105.42M |
| Total Cash/Share | 0.82 |
| Total Debt | 1.99M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.03 |
| Book Value Per Share | 1.12 |
| 52-Week Change | 216.44 |
| 52-Week High | 10.87 |
| 52-Week Low | 0.61 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 4.31 |
| Average Volume | 12,279 |
| Shares Outstanding | 124.88M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |